Search Within

Andrew D Zelenetz

Formats
  1. Meeting Abstract (461)
  2. Journal Article (288)
  3. Research Letter (14)
  4. Book Section (7)
  5. Guidelines (5)
  6. Conference Paper (3)
  7. Correspondence (3)
  8. Editorial (3)
  9. Review (1)
Groups
  1. Center for Hematologic Malignancies (785)
  2. Department of Medicine (785)
  3. Hematologic Malignancies, Division of (785)
  4. Lymphoma (785)
  5. Survivorship Research (234)
  6. Population Sciences Research Program (189)

More Groups

People
  1. Craig Moskowitz (207)
  2. Ariela Noy (188)
  3. Paul Hamlin (187)
  4. Steven Horwitz (169)
  5. David Straus (163)
  6. Maria Palomba (143)

More People

Years
  1. 2025 (8)
  2. 2024 (31)
  3. 2023 (43)
  4. 2022 (30)
  5. 2021 (29)
  6. 2020 (32)

More Years

Publications
  1. Blood (329)
  2. Journal of Clinical Oncology (83)
  3. Journal of the National Comprehensive Cancer Network (35)
  4. British Journal of Haematology (34)
  5. Leukemia and Lymphoma (31)
  6. Annals of Oncology (26)

More Publications

Publishers
  1. American Society of Hematology (341)
  2. American Society of Clinical Oncology (85)
  3. John Wiley & Sons (41)
  4. Harborside Press (35)
  5. Elsevier Inc. (31)
  6. Oxford University Press (31)

More Publishers

Results (785)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
    Journal Article

    Kaminski, M. S.; Zelenetz, A. D.; Press, O. W.; Saleh, M.; Leonard, J.; Fehrenbacher, L.; Lister, T. A.; Stagg, R. J.; Tidmarsh, G. F.; Kroll, S.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas
    Journal Article

    Chen, W.; Palanisamy, N.; Schmidt, H.; Teruya-Feldstein, J.; Jhanwar, S. C.; Zelenetz, A. D.; Houldsworth, J.; Chaganti, R. S. K.
    Oncogene (2001)

    Fulltext@MSK | Save
  • Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma
    Journal Article

    Cohen, B. J.; Moskowitz, C.; Straus, D.; Noy, A.; Hedrick, E.; Zelenetz, A.
    Leukemia and Lymphoma (2001)

    Fulltext@MSK | Save
  • Establishment of a human cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma
    Journal Article

    Goy, A.; Gilles, F.; Remache, Y.; Filippa, D.; Portlock, C. S.; Jhanwar, S. C.; Zelenetz, A. D.
    Leukemia and Lymphoma (2001)

    Fulltext@MSK | Save
  • Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: Results from a sequential treatment CLL protocol
    Journal Article

    Noy, A.; Verma, R.; Glenn, M.; Maslak, P.; Rahman, Z. U.; Keenan, J. R.; Weiss, M.; Filippa, D.; Zelenetz, A. D.
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • MUC 1 and MDC 15 dysregulation in extra-nodal B-cell lymphomas
    Meeting Abstract

    Gilles, F.; Goy, A.; Remache, Y.; Zelenetz, A. D.
    Acta Haematologica (2000)

    Fulltext@MSK | Save
  • Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data
    Meeting Abstract

    Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Radford, J. A.; Wahl, R. L.; Rohatiner, A.; Kroll, S.; Stagg, R.; Nadeau, K.; Valente, N.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save